# Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism

> **NCT02059733** · PHASE2 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 72 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** 18F-DTBZ

## Key facts

- **NCT ID:** NCT02059733
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-07-31
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2018-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02059733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02059733, "Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02059733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*